Published in Br J Pharmacol Chemother on November 01, 1967
Mediators of the inflammation induced in the rat paw by carrageenin. Br J Pharmacol (1971) 1.93
Some pharmacodynamic properties of cellulose sulphate, a kininogen-depleting agent in the rat. Br J Pharmacol Chemother (1968) 1.58
The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma. J Exp Med (1970) 1.44
Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system. J Clin Invest (1972) 1.08
Histamine release from platelets for assay of byssinogenic substances in cotton mill dust and related materials. Br J Ind Med (1979) 0.97
Lowering of kininogen in rat blood by adrenaline and its inhibition by sympatholytic agents, heparin and aspirin. Br J Pharmacol (1974) 0.81
Arachidonic acid-induced paw oedema in the rat [proceedings]. Br J Pharmacol (1976) 0.75
Formation of plasma kinins by plasmin. J Physiol (1958) 4.14
Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol (1958) 3.14
ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. J Lab Clin Med (1964) 2.70
Role of Hageman factor in the activation of vasodilator activity in human plasma. Nature (1961) 1.82
The mode of action of Hageman factor in the release of plasma kinin. J Physiol (1960) 1.42
KINIRASE ACTIVITY OF HUMAN SALIVA. Nature (1964) 1.41
Substrates for plasma kinin-forming enzymes in rat and guinea-pig plasma. Br J Pharmacol Chemother (1966) 1.15
Purification of a kinin-inactivating enzyme from cultures of Pseudomonas aeruginosa. Br J Pharmacol Chemother (1967) 1.13
STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID. J Lab Clin Med (1964) 1.12
Characterization of a plasma kinin-inactivating enzyme produced by Pseudomonas aeruginosa. Br J Pharmacol Chemother (1967) 1.10
Significance of the callicreincallidinogen-callidin system in shock. Am J Physiol (1959) 0.94
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32
Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med (2013) 1.90
[Doxazosin (Carduran)--a research survey]. Tidsskr Nor Laegeforen (1993) 1.39
[Medical research at Norwegian universities]. Tidsskr Nor Laegeforen (1998) 1.38
Cadmium resistance and content of cadmium-binding protein in two enzyme-deficient mutants of mouse fibroblasts (L-cells). Biochem Pharmacol (1978) 1.25
A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature (1996) 1.19
Rat submandibular gland kallikreins: purification and cellular localization. Br J Pharmacol (1976) 1.17
Purification of a kinin-inactivating enzyme from cultures of Pseudomonas aeruginosa. Br J Pharmacol Chemother (1967) 1.13
Consumption of kininogen in the submandibular salivary gland when activated by chorda stimulation. J Physiol (1970) 1.11
Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas. Br J Cancer (1981) 1.10
Characterization of a plasma kinin-inactivating enzyme produced by Pseudomonas aeruginosa. Br J Pharmacol Chemother (1967) 1.10
Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty-acid-induced transcription. Eur J Biochem (1994) 1.03
A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture. Endocrinology (1976) 1.01
Regulation of salivary kallikrein secretion in submandibular gland. Acta Physiol Scand (1977) 1.01
Effects of thyroliberin and 4-aminopyridine on action potentials and prolactin release and synthesis in rat pituitary cells in culture. Acta Physiol Scand (1980) 1.00
Sox-4 messenger RNA is expressed in the embryonic growth plate and regulated via the parathyroid hormone/parathyroid hormone-related protein receptor in osteoblast-like cells. J Bone Miner Res (2000) 1.00
Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol (1981) 0.99
Effects of sex steroids on prolactin secreting rat pituitary cells in culture. Endocrinology (1976) 0.95
Glandular kallikreins. Gen Pharmacol (1978) 0.95
Radioresistance in cells with high content of metallothionein. Experientia (1982) 0.93
The immunological similarity of rat glandular kallikreins. Biochem J (1977) 0.93
Pharmacokinetics of methyldopa in healthy man. Eur J Clin Pharmacol (1977) 0.92
Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res (1983) 0.92
An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum (1987) 0.91
Metabolism of bilirubin by a clonal strain of rat hepatoma cells. J Cell Biol (1970) 0.91
A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis. Clin Rheumatol (1986) 0.91
Calcium status and calcium-regulating hormones in alcoholics. Alcohol Clin Exp Res (1988) 0.90
Effects of cations and colchicine on the release of prolactin and growth hormone by functional pituitary tumor cells in culture. Endocrinology (1973) 0.90
Tumours from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum. Acta Pharmacol Toxicol (Copenh) (1984) 0.89
Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem Biophys Res Commun (1993) 0.89
Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling. N Engl J Med (1974) 0.89
Stimulation of prolactin synthesis and of adenosine 3':5'-cyclic phosphate formation by prostaglandins and thyroliberin in cultured rat pituitary cells. Biochem J (1976) 0.89
Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration. Eur J Clin Pharmacol (1983) 0.88
Characterization of a human epithelial cell line with special reference to its ultrastructure. Acta Pathol Microbiol Scand A (1981) 0.88
Chemosensitivity measurements of human tumour cells by soft agar assays are influenced by the culture conditions. Br J Cancer (1985) 0.88
Transfer of bilirubin uridine diphosphate-glucuronyltransferase to enzyme-deficient rats. Science (1970) 0.88
Induction of peroxisomal acyl-CoA oxidase by 3-thia fatty acid, in hepatoma cells and hepatocytes in culture is modified by dexamethasone and insulin. Biochim Biophys Acta (1993) 0.88
Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int (1986) 0.87
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrob Agents Chemother (1991) 0.87
Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi. Eur J Biochem (1989) 0.86
Human medullary thyroid carcinoma: control of calcitonin secretion in vivo and in tissue culture. Horm Metab Res (1974) 0.86
Labeled bilirubin production by a clonal strain of rat hepatoma cells. Proc Soc Exp Biol Med (1971) 0.85
Serum concentrations of theophylline in children following the administration of doses generally recommended: new dosage regimen required. Acta Paediatr Scand (1979) 0.85
Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes, and erythrocytes: relevance to toxicity and monitoring in recipients of renal allografts. Ther Drug Monit (1997) 0.85
Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines. Br J Cancer (1996) 0.85
Bone changes after castration in rats. A model for osteoporosis. Acta Orthop Scand (1986) 0.85
On the role of extracellular Ca2+ for prolactin release and adenosine 3':5'-monophosphate formation induced by thyroliberin in cultured rat pituitary cells. Life Sci (1980) 0.84
Effects of prostaglandins on prolactin and growth hormone synthesis and secretion in cultured rat pituitary cells. Endocrinology (1976) 0.84
Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells. Ther Drug Monit (1997) 0.84
Acute effects of paracetamol on prostaglandin synthesis and renal function in normal man and in patients with renal failure. Clin Nephrol (1990) 0.83
Cultured human cells with a high content of metallothionein show resistance against gold-chloride. Scand J Rheumatol (1983) 0.83
Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells. Acta Endocrinol (Copenh) (1985) 0.83
Epidemiology of NSAID-related gastrointestinal side effects. Scand J Gastroenterol Suppl (1989) 0.83
Thyroliberin receptor binding and adenylyl cyclase activation in cultured prolactin-producing rat pituitary tumor cells (GH cells). J Biol Chem (1983) 0.82
Kininogenase activity in the stimulated submandibular salivary gland in cats. Acta Physiol Scand (1972) 0.82
Consumption of the plasma substrate for glandular kallikrein on activation of the submandibular salivary gland. J Physiol (1968) 0.82
Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+. Mol Cell Endocrinol (1987) 0.82
Cell-specific expression and function of adenylyl cyclases in rat pituitary tumour cell lines. Eur J Biochem (1994) 0.82
Surgically induced uremia in rats. I: Effect on bone strength and metabolism. Biosci Rep (1993) 0.82
Interaction of cyclosporin and its solvent, Cremophor, with atracurium and vecuronium. Studies in the cat. Br J Anaesth (1986) 0.81
Variations in prolactin and growth hormone production during cellular growth in clonal strains of rat pituitary cells. J Cell Physiol (1977) 0.81
Transcription of the human thyrotropin-releasing hormone receptor gene-analysis of basal promoter elements and glucocorticoid response elements. Biochem Biophys Res Commun (1999) 0.81
Effects of colchicine and 2-Br-alpha-ergocryptine-methane-sulfonate (CB 154) on the release of prolactin and growth hormone by functional pituitary tumor cells in culture. J Cell Physiol (1973) 0.81
5-azacytidine-induced alterations in the GH12C1 cells: effects on cellular morphology, chromosome structure, DNA and protein synthesis. J Cell Sci (1989) 0.81
Changes in pharmacokinetics of cisplatin after hepatic resection in rats. Drug Metab Dispos (1991) 0.81
Acquired resistance against gold(III)-chloride in cultured human cells. Scand J Rheumatol (1985) 0.81
Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cells. Mol Cell Endocrinol (1982) 0.81
Specific antisense RNA inhibition of growth hormone production in differentiated rat pituitary tumour cells. Biochem Biophys Res Commun (1990) 0.81
Trifluoperazine blocks calcium-dependent action potentials and inhibits hormone release from rat pituitary tumour cells. Eur J Pharmacol (1982) 0.81
The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice. Leukemia (2002) 0.81
Influence of certain chelating agents on egress of cadmium from cultured epithelial cells containing high amounts of metallothionein: a screening of Cd-releasing and toxic effects. Acta Pharmacol Toxicol (Copenh) (1981) 0.81
Metallothionein--a unique protein with multiple detoxifying properties? Eur Surg Res (1984) 0.81
Plasma-kinins and adrenergic vasodilatation in the submandibular salivary gland of the cat. Acta Physiol Scand (1972) 0.81
Structural and functional organization of the gene encoding the human thyrotropin-releasing hormone receptor. J Neurochem (1999) 0.80
Effects of sex steroids on growth hormone production in cultured rat pituitary cells. Acta Endocrinol (Copenh) (1978) 0.80
Cyclosporine in living related and cadaveric renal transplantation. Transplant Proc (1984) 0.80
Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein. Cytometry (1995) 0.80
Metallothionein: a protein conferring resistance in vitro to tumor necrosis factor. Cancer Res (1993) 0.80
Expression of human parathyroid hormone in mammalian cells, Escherichia coli and Saccharomyces cerevisiae. J Biotechnol (1994) 0.80
Pharmacokinetics of oral 6-mercaptopurine: relationship between plasma levels and urine excretion of parent drug. Ther Drug Monit (1990) 0.80
Acquired resistance to auranofin in cultured human cells. Scand J Rheumatol (1985) 0.80
Stereological and biochemical analysis of prolactin and growth hormone secreting rat pituitary cells in culture. Stereology combined with non-parametrical statistics. Cell Tissue Res (1977) 0.80
Clinical pharmacokinetics of methyldopa. Clin Pharmacokinet (1982) 0.80
Uptake and egress of cadmium in cultures of cadmium-resistant and the corresponding "wild-type" cells. Acta Pharmacol Toxicol (Copenh) (1981) 0.80
Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents. Leukemia (1999) 0.80
Protective function of metallothionein against certain anticancer agents. Experientia Suppl (1987) 0.79
Cultured human cells with high levels of gold-binding cytosolic metallothionein are not resistant to the growth inhibitory effect of sodium aurothiomalate. Ann Rheum Dis (1986) 0.79
Increase in plasma calcitonin following femoral fracture in rats. Acta Orthop Scand (1981) 0.79
Para-aminophenol metabolism in an established cell line with liver-like functions. Acta Pharmacol Toxicol (Copenh) (1972) 0.79
Ploidity and cell cycle progression during treatment with gold chloride, auranofin and sodium aurothiomalate. Studies on a human epithelial cell line and its sub-strains made resistant to the antiproliferative effects of these gold compounds. Virchows Arch B Cell Pathol Incl Mol Pathol (1985) 0.79
Phorbol esters and thyroliberin have distinct actions regarding stimulation of prolactin secretion and activation of adenylate cyclase in rat pituitary tumour cells (GH4C1 cells). Biochem Pharmacol (1988) 0.79
Sodium and calcium action potentials in cells derived from a rat medullary thyroid carcinoma. Acta Physiol Scand (1981) 0.79
Relationship between stimulated prolactin release from GH cells and cyclic AMP degradation and formation. Mol Cell Endocrinol (1982) 0.79
Different properties of microsomal UDP-glucuronyltransferase in buffalo rat liver and a clonal strain of rat hepatoma cells derived from the same rat strain. Acta Pharmacol Toxicol (Copenh) (1973) 0.79
Stability of cadmium resistance and metallothionein levels in vitro and in vivo. Toxicol Appl Pharmacol (1983) 0.79
Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatment. Ther Drug Monit (1994) 0.79
Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone. J Protein Chem (1991) 0.79
Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP). Int J Clin Pharmacol Ther (2000) 0.79
Electroporation of rat pituitary (GH) cell lines: optimal parameters and effects on endogenous hormone production. Biochem Biophys Res Commun (1990) 0.79